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Abstract
Background: We investigated parent-of-origin and allele-specific expression effects on obesity and hepatic gene
expression in reciprocal crosses between the Berlin Fat Mouse Inbred line (BFMI) and C57Bl/6NCrl (B6N).
Results: We found that F1-males with a BFMI mother developed 1.8 times more fat mass on a high fat diet at 10
weeks than F1-males of a BFMI father. The phenotype was detectable from six weeks on and was preserved after
cross-fostering. RNA-seq data of liver provided evidence for higher biosynthesis and elongation of fatty acids
(p = 0.00635) in obese male offspring of a BFMI mother versus lean offspring of a BFMI father. Furthermore, fatty
acid degradation (p = 0.00198) and the peroxisome pathway were impaired (p = 0.00094). The circadian rhythm was
affected as well (p = 0.00087). Among the highest up-regulated protein coding genes in obese males were Acot4 (1.82
fold, p = 0.022), Cyp4a10 (1.35 fold, p = 0.026) and Cyp4a14 (1.32 fold, p = 0.012), which hydroxylize fatty acids and which
are known to be increased in liver steatosis. Obese males showed lower expression of the genetically imprinted and
paternally expressed 3 (Peg3) gene (0.31 fold, p = 0.046) and higher expression of the androgen receptor (Ar) gene (2.38
fold, p = 0.068). Allelic imbalance was found for expression of ATP-binding cassette transporter gene Abca8b. Several of
the differentially expressed genes contain estrogen response elements.
Conclusions: Parent-of-origin effects during gametogenesis and/or fetal development in an obese mother epigenetically
modify the transcription of genes that lead to enhanced fatty acid synthesis and impair β-oxidation in the liver of male,
but not female F1 offspring. Down-regulation of Peg3 could contribute to trigger this metabolic setting. At puberty,
higher amounts of the androgen receptor and altered access to estrogen response elements in affected genes are
likely responsible for male specific expression of genes that were epigenetically triggered. A suggestive lack of
estrogen binding motifs was found for highly down-regulated genes in adult hepatocytes of obese F1 males
(p = 0.074).
Keywords: Allele-specific gene expression, Allelic imbalance, High fat diet, Imprinting, Peg3, Circadian rhythm,
Sex differences, Sex hormones
Background
Besides nutrition and sedentary lifestyle, genetic predis-
position contributes to obesity. To assess the genetic de-
terminants of obesity, many large-scale genome-wide
association studies were performed in different human
populations. These studies led to the identification of
about 350 genomic loci contributing to obesity [1].
However, their effects are small and the overall
contribution of all detected loci to the variance in a
population was small (0.01 % to 0.34 %) [2–6]. There-
fore, additional factors could contribute to obesity in an
individual. Missing heritability can be hidden in genetic
effects of rare alleles, epistatic interaction and gene-by-
environment interaction, but can be also contributed to
by parent-of-origin specific effects. Parent-of-origin
effects include the Y chromosome, mitochondria,
parental-specific genetic imprinting, and maternal envir-
onmental effects during pregnancy and the suckling
period.
In a mouse model of juvenile obesity, we tested,
if parental obesity influences the transmission of
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predisposition for adiposity to F1 offspring. We used
the Berlin Fat Mouse Inbred line (BFMI) which car-
ries a recessive mutation responsible for high fat de-
position in particular during early development
between four and ten weeks [7]. At ten weeks BFMI
males are 5.5 times as obese as C57BL/6Nrl mice
(B6N).
In reciprocal crosses between BFMI and B6N mice
we tested the development of obesity in F1 males and
females and their response to the obese parent with
respect to gene expression in the liver. The results
provide evidence for regulation of genes by the influ-
ence of the direction-of-cross, which leads to obesity




Reciprocal crosses were generated from the Berlin Fat
Mouse Inbred line BFMI860-12/Hber (BFMI) and
C57BL/6NCrl (B6N). Seven BFMI males were mated
with seven B6N females and six B6N males with six
BFMI860 females to generate 48 F1 animals (deemed
patBFMI and matBFMI, respectively). Each reciprocal
F1 offspring groups consisted of 12 males and 12 fe-
males. From these animals three F1 males (matBFMI)
from three BFMI females and three F1 males
(patBFMI) from three B6N females were used for
RNA-seq transcriptome measurements. One high fat
diet raised male and female from each inbred parental
strain (BFMI and B6N) were used as parental strain
control animals and measured via RNA-seq as well.
For the cross-fostering experiment, six BFMIxB6N
and six B6NxBFMI crosses generated two additional
groups of reciprocal F1 animals with a total of 88 an-
imals, 46 with a BFMI father (23 males, 23 females)
and 42 with a BFMI mother (24 males, 18 females).
For cross-fostering, litters were exchanged between
B6N and BFMI mothers within 12 hours after birth.
The litter size ranged between four and eleven off-
spring. Two animals per cross-fostering group were
excluded due to outlier testing (R-package “outliers”).
Parents were fed a standard breeding diet (SBD).
F1-animals were fed a high fat diet (HFD) from wean-
ing at 21 days until 70 days when offspring was
euthanized and dissected. The SBD contained 16.7
MJ/kg of metabolisable energy, 11 % from fat, 36 %
from proteins and 53 % from carbohydrates (V1534-
000, ssniff EF R/M, Ssniff GmbH, Soest/Germany). The
HFD contained 19.5 MJ/kg of metabolisable energy, 45 %
from fat, 24 % from proteins and 31 % from carbohydrates
(E15103–34, ssniff EF R/M, Ssniff GmbH, Soest/Germany).
All experimental treatments of animals were approved by
the German Animal Welfare Authorities (approval no.
G016/11).
Phenotyping
Body weight and body composition (total lean mass,
total fat mass) were recorded weekly from week three
and four. Body composition was measured using
EchoMRI whole-body composition analyzer (Echo Med-
ical Systems, Houston, TX, USA). At ten weeks blood
glucose levels were measured prior to dissection after 2
hours of fasting using a glucometer (Contour, Bayer,
Leverkusen, Germany). Liver triglycerides and proteins
were measured in homogenized liver samples by
commercially available kits (DC Protein Assay, Bio-Rad,
München, Germany; TRIGS Triglycerides Assay,
Randox, Crumlin, United Kingdom). For test statistics
between the matBFMI and patBFMI, we applied a linear
model using anova in R. Since litter size had a significant
effect on all traits, phenotypic values were adjusted for
litter size before statistic tests were performed, except
for blood glucose and liver triglycerides.
RNA preparation and sequencing
RNA sequencing was performed on 10 liver samples: 1
male and 1 female B6N mouse, 1 male and 1 female
BFMI mouse, 3 F1 (BFMI x B6N) males (patBFMI), and
3 F1 (B6N x BFMI) males (matBFMI). The F1 males
were of non-cross-fostered mice. Tissue samples were
frozen in liquid nitrogen and stored at –80 °C until RNA
preparation. RNA was prepared using the RiboZero
RNA library protocol. Paired end RNA sequencing was
run on an Illumina HiSeq2000 machine.
Analysis of RNA-Seq data
After sequencing, bcl2fastq v1.8.4 [8] was used for base
calling and demultiplexing. Paired end reads were
trimmed using Trimmomatic [9] using standard settings.
TruSeq3-PE adapter sequences provided by Illumina were
used for adapter trimming. Reads were aligned against
Mus musculus GRCm38 reference genome (Ensembl)
using BWA [10], after which GATK [11] was applied to
do base quality score recalibration, indel realignment, du-
plicate removal, SNP/INDEL discovery and genotyping
across all 10 samples using standard hard filtering param-
eters or variant quality score recalibration according to
GATK Best Practices recommendations [12].
Raw reads from RNA-Seq data were extracted from
BAM files using the GenomicFeatures package using the
Mus_musculus.GRCm38.81.gtf file obtained from ensembl,
overlap between genes and raw reads was calculated in
‘union’ mode using the Rsamtools package [13]. Reads
were quantile normalized between samples using the pre-
processCore package. After sample quantile normalization,
RPKM values for each gene were calculated, which were
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then log transformed ( ln(n + 1) ) to reduce the effect of ex-
treme RPKM values in subsequent statistical tests. The bio-
maRt R package was used to provide additional gene
annotation such as MGI descriptions (using the M. muscu-
lus ensembl database GRCm38.p4).
We analyzed the gene expression of the reciprocal F1
populations with respect to differentially expressed
genes, pathways, and allele specific expression. Testing
for differences between the two groups of reciprocal
crosses was done using two sided t-tests. Due to limited
sample sizes of three animals per F1 group, adjustment
for multiple testing was not applied for differential gene
expression analysis. The original transcriptome sequen-
cing data for all ten animals tested are available at the
GEO database (http://www.ncbi.nlm.nih.gov/geo/).
Pathway analyses
Genes that were differentially expressed (p < 0.05) between
the two groups of F1 males with RPKM values > 0.5 in at
least one of the F1 groups and gene expression differences
of > = 20 % were subjected to overrepresentation analyses
in KEGG pathways using innateDB [14] to identify path-
ways associated with these genes [15]. We used the default
hypergeometric algorithm and the Benjamini Hochberg
algorithm for multiple testing corrections. Heatmaps were
created for selected pathways using the mean gene expres-
sion per group.
Analysis of allele specific expression (ASE)
To assess ASE in the reciprocal F1 crosses, bcftools was
used to perform SNPs calling on the entire population (all
10 animals: 2 BFMI, 2 B6N, 3 matBFMI, 3 patBFMI). De-
tected SNPs underwent a rigorous data quality checks to
make sure detected SNPs showed sufficient coverage in the
entire population. The individuals from the BFMI and B6N
pure lines were analyzed to detect homozygous SNPs that
showed different alleles between B6N and BFMI. We
demanded that all SNPs found in the four parental strain
animals had non-missing data (neither low confidence nor
low coverage). SNPs were called using the samtools mpi-
leup tool. Subsequently, the generated bcf file was proc-
essed using BCFtools [16] and filtered using the provided
vcfutils.pl script for SNPs with a 100 reads minimum for
the entire population (over all 10 animals). After using the
entire population for SNP calling, we reanalyzed all SNPs
per individual using the samtools mpileup tool to obtain
DP4 measurements for each F1 individual. SNPs with low
confidence (Phred probability threshold < 50) or less than 5
high quality reads in an individual were excluded from fur-
ther analyses. Allele ratios alt/(ref + alt) were calculated for
all remaining SNPs. Additionally, we filtered for consistency
between the different individuals from the same F1 cross
direction. If the standard deviation of the alt/(ref + alt) ra-
tios across the 3 individuals per F1 group was > 20 %, the
SNP was removed due to the fact that the data was not
consistent across the individuals.
After filtering for high quality SNPs which are homozy-
gous (but different) between the parental strains, χ 2 scores
were calculated for each individual. χ2 scores were adjusted
to account for direction of the effect (< 50 % vs. > 50 %)
and scores were square root transformed to minimize the
impact of a single F1 individual (in the F1 groups) showing
a highly significant deviation from the expected 50:50 ratio.
Summed scores across all individuals in a F1 cross direction
(matBFMI and patBFMI) were calculated to obtain a group
based χ2 score, which were then subtracted from each other
to get a group difference score per SNP. To account for
over dispersion in the read counts obtained from the DP4
values, we permuted our group based χ2 scores to obtain a
5 % FDR threshold for SNPs that show significant ASE in
either the patBFMI or the matBFMI group.
Analysis of transcription factor binding sites
Differentially expressed genes (p < 0.05) were submitted to
transcription factor binding site (TFBS) analysis. For each
gene we extracted the upstream (2000 bp) and down-
stream (1000 bp) region around the transcription start
using the TxDb.Mmusculus.UCSC.mm10 package from
bioconductor [17]. All known mouse TFBS motifs were
downloaded from the Jaspar database into R using the
MotifDb package [18, 19].
Each gene region of 3000 basepairs was scanned for
all estrogen receptor related motifs in the Jasper
database using the Biostrings package [20], for each motif
we recorded the number of matches within the 3000 bp
region (Mmusculus-jolma2013-Esrra-2 -UniPROBE-Esrra.
UP00079, -JASPAR_CORE-Esrrb-MA0141.1, -JASPAR_
2014-Esrrb-MA0141.2). Additionally, position weight
matrices for estrogen receptor alpha (ER), estrogen
response element (ERE) and the binding site for gluco-
corticoid receptor (GR)[21, 22] were applied as well.
Since only one weight matrices (jolma2013-Ar) was
available in the Jasper database for androgen response
elements (AREs) in mouse, we created position weight
matrices for androgen response elements using the
motifs from Shaffer et al. for ARE, ARE2, ADR3, IR3
[23]. We used a conservative threshold of 90 % for
sensitivity and specificity. A list of the applied pos-
ition weight matrices is given in Additional file 1:
Table S3.
Additionally, we compared the occurrence of TFBS in
both differentially and allele specific expressed genes
with 1,000 permutations of random sets of genes of the
respective same group size.
Quantitative PCR
RNA from ten male matBFMI and ten male patBFMI
was extracted from liver tissue. Total RNA was isolated
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from liver tissue using the NucleoSpin RNA II kit
(Macherey-Nagel, Düren, Germany). One μg of total
RNA was reverse-transcribed into cDNA using Accu-
Script High Fidelity Transcriptase (Stratagene Europe,
Amsterdam, Netherlands) and Oligo (dT) primers
(Ark Scientific, Sigma-Aldrich, München, Germany).
The cDNA integrity was checked in a polymerase
chain reaction (PCR). For semi-quantitative real-time
PCR 20 ng cDNA was mixed with the qPCR master-
mix of the Plus Kit for SYBR Green (Eurogentec, Co-
logne, Germany) and 300 nM of the primers at a
final volume of 10 μl per reaction. The amplification
protocol included a 10 min DNA denaturation step at
95 °C, followed by 40 cycles consisting of 20 s at
60 °C and 40 s at 72 °C. Quantification of mRNA
transcript amounts was performed using the Applied
Biosystems® ViiA™ 7 Real-Time PCR System and
ViiA™ Software v.1.2.1. Primers for target genes Ar,
Peg3 and Srebf1 were designed using Primer3web
[24]. Sequences for reference gene primers (Actb,
Mrpl46, Srp72) were taken from Hruz et al. [25]. The
geometric mean of the three reference genes was used
to normalize target gene expression. Relative quantifi-
cation of gene expression was performed according to
ABI's user guide [26]. Further details are provided in
Additional file 2: Table S4.
Results and discussion
Phenotypes
Since BFMI animals carry a major recessive mutation lead-
ing to juvenile obesity in homozygous carriers [27], we ex-
pected lean F1-offspring in either cross direction. However,
data provided evidence for the development of obesity in
F1 males, if the mother originates from the obese BFMI line
(matBFMI), while females of the same cross direction and
both sexes of the reciprocal cross had normal body weight
and fat mass (Table 1). Body mass did not differ signifi-
cantly between offspring of the reciprocal crosses, but F1
males from BFMI mothers (matBFMI) had 1.83 times more
adipose tissue mass at 10 weeks (p = 0.0037) than F1 males
from BFMI fathers (patBFMI). Since the lean mass was only
marginally lower in the obese matBFMI versus the lean
patBFMI F1 males (0.98 fold, p = 0.054), the fat to lean
mass ratio was also 1.86 times higher in matBFMI males
(p = 0.0009). Moreover, matBFMI also showed ectopic fat
storage in the liver with fat content being 1.30 times higher
than in patBFMI males from the reciprocal cross
(p = 0.084). The higher fat mass in matBFMI males began
at puberty and was significant from seven weeks on (Fig. 1).
A cross-fostering experiment was performed to assess
the influence of postnatal maternal effects such as milk
energy content and behavior during the suckling period
on later development of fat deposition in offspring. This
Table 1 Phenotypes of 10 weeks old males and females of reciprocal crosses between BFMI and B6N with and without cross-fostering
on high fat diet
Phenotypes1 F1(BFMI x B6N) F1(B6N x BFMI) p-Value for direction-
of-cross effectBFMI father (patBFMI) BFMI mother (matBFMI)
Males Females Males Females Males Females
Maternal fostering
Body mass (g) 34.23 (3.26) 26.16 (2.02) 36.82 (3.96) 25.27 (2.06) n.s. n.s.
Fat mass (g) 3.86 (1.49) 3.34 (1.01) 7.06 (2.56) 3.44 (1.04) 0.0037 n.s.
Lean mass (g) 27.54 (2.06) 20.45 (1.00) 26.93 (2.10) 19.68 (1.09) 0.0536 0.0855
Fat / Lean mass ratio 0.14 (0.05) 0.16 (0.04) 0.26 (0.08) 0.17 (0.05) 0.0009 n.s.
Liver mass (g) 1.55 (0.23) 1.21 (0.10) 1.68 (0.18) 1.16 (0.12) n.s. n.s.
Liver triglycerides/ protein (μg/μg) 0.45 (0.09) 0.47 (0.11) 0.59 (0.22) 0.45 (0.08) 0.0843 n.s.
Blood glucose levels (mg/dl) 165.33 (27.20) 135.92 (12.22) 174.25 (23.80) 133.25 (10.71) n.s. n.s.
Cross-fostering
Body mass (g) 34.27 (3.41) 25.96 (3.75) 35.63 (2.65) 24.36 (1.71) n.s. n.s.
Fat mass (g) 4.06 (2.06) 3.45 (1.56) 5.54 (1.74) * 2.70 (0.99) 0.0142 n.s.
Lean mass (g) 29.54 (1.84) ** 21.69 (3.06) 29.61 (1.68) ** 20.64 (1.19) ° n.s. n.s.
Fat / Lean mass ratio 0.14 (0.06) 0.16 (0.07) 0.19 (0.06) ** 0.13 (0.04) ° 0.0067 n.s.
Liver mass (g) 1.66 (0.21) 1.22 (0.23) 1.75 (0.15) 1.17 (0.13) n.s. n.s.
Liver triglycerides/ protein (μg/μg) 0.15 (0.09)** 0.34 (0.17)° 0.21 (0.08)** 0.26 (0.13)** 0.0307 n.s.
Blood glucose levels (mg/dl) 137.82 (19.07) ** 130.36 (13.13) 151.83 (22.7) * 139.29 (20.64) 0.0307 n.s.
1shown are means ± standard deviation after correction for litter size, except for blood glucose and liver triglycerides, which were not affected by the litter size.
Asterisks additionally indicate significant effects of cross fostering on phenotypes comparing animals of the same direction of cross (patBFMI vs. cross-fostered
patBFMI, matBFMI vs. cross-fostered matBFMI) (**p < 0.01, *p < 0.05, °p < 0.1)
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experiment validated the results obtained before, but fat
deposition was a little lower (Fig. 1). Cross-fostering led
to a reduction of adipose tissue mass in male and female
F1 offspring of BFMI mothers by approximately 22 % if
they were raised by lean B6N foster mothers. Cross-
fostered F1 males of BFMI mothers still developed 1.36
times higher fat mass (p = 0.0142), had a 1.36 times higher
fat to lean ratio (p = 0.0067), 1.40 times higher hepatic tri-
glyceride levels (p = 0.03070) and higher blood glucose
levels (1.10 fold, p = 0.03073) than cross-fostered F1 males
of the reciprocal cross (Table 2). These data support an ef-
fect of the suckling period on later obesity and diabetes
development that has been shown before [28–30].
Differential gene expression between F1 males of BFMI
mothers and BFMI fathers
Since lipid accumulation of F1 males differed between the
reciprocal crosses, we investigated the direction-of-cross
effect on hepatic gene expression profiles in males. Over-
representation analyses of genes that were differentially
expressed between the two groups of reciprocal F1 males
at p < 0.05 and a fold-change difference of at least 20 %
provided evidence for alterations of pathways for lipid me-
tabolism, peroxisome, circadian rhythm, cellular transport
processes and the endocrine system as a results of the
direction of cross (Table 2, Table 3). Most genes with
higher expression in the obese F1 males control the
cellular utilization of fatty acids for energy production
or fat synthesis including the hydrolysis of triglycer-
ides into free fatty acids and glycerol, the conversion
of free fatty acids into fatty acyl-CoA esters, the bio-
synthesis of saturated fatty acids or the degradation
and conversion into acetyl-CoA by β-oxidation [31]
(Fig. 2). But also genes for the transport between per-
oxisome and mitochondria via carnitine [32, 33] and
the electron carrier generation by the citrate cycle
and the respiratory chain in mitochondria were differ-
entially expressed.
The metabolic changes in obese males were associated
with a shift of the circadian rhythm, in which the gene
Fig. 1 Development of phenotypes of males and females on a high fat diet of the two reciprocal F1-crosses until 10 weeks. The figures show means ±
standard deviations of the total fat mass and the total fat mass-to-total-lean mass-ratios in F1-animals without (a and b, respectively) and
with cross-fostering (c and d, respectively). Paternal and maternal BFMI (pat, mat) indicates direction of cross. Asterisks indicate significant
differences between different reciprocal crosses for males (blue) and females (red) and significant differences within the same reciprocal
cross between males and females of matBFMI (orange) and patBFMI (grey) (***p < 0.001, **p < 0.01, *p < 0.05)
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Table 2 KEGG pathways affected by the direction of cross in F1 males (p < 0.05)
KEGG
ID
Major category/Subcategory Pathway Name Proportion of
genes in pathway
Identified genes 1 fold-change
(matBFMI vs. patBFMI)




Circadian rhythm 10 % Arntl (0.54) - 0.00087
Per2 (1.32) -
Per3 (1.71) -
04146 Cellular Processes/Transport and
catabolism














00590 Metabolism/Lipid metabolism Arachidonic acid
metabolism












00061 Metabolism/Lipid metabolism Fatty acid biosynthesis 14 % Acsl3 (1.22) - 0.00282
Fasn (1.22) ERE








00062 Metabolism/ Lipid metabolism Fatty acid elongation 8 % Acot4 (1.82) - 0.00627
Elovl6 (1.32) -
00140 Metabolism/Lipid metabolism Steroid hormone
biosynthesis






01040 Metabolism/ Lipid metabolism Biosynthesis of
unsaturated fatty
acids












ABC transporters 4 % Abcd1 (1.22) - 0.01649
Abcd2 (1.52) -
00591 Metabolism/ Lipid metabolism 4 % Cyp2c38 (1.61) 0.01884
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Arntl (0.54 fold, p = 0.01), was down- and Per2 (1.32
fold, p =0.02) and Per3 (1.71 fold, p = 0.03) were up-
regulated (Table 2). Disruptions of the normal circadian
rhythm have been linked to obesity in Clock [34] and
Arntl (alias Bmal1) knock-out mice and feeding experi-
ments [35]. A shift of the circadian rhythm in offspring
as a result of in utero exposure to maternal obesity has
been shown in rats [36].
Indications for impaired β-oxidation in the obese males
were found from up-regulated expression of cytoplasmic
acetyl-CoA carboxylase (Acaca, 1.20 fold, p < 0.06) and cit-
rate lyase (Acly, fold 1.11, p < 0.08), which usually inhibits
the cytosol-mitochondria transport of the fatty acid de-
rived substrates via allosteric inhibition of Crat (1.27 fold,
p = 0.01) by malonyl-CoA [37–39]. Furthermore, acyl-
CoA thioesterases (Acot) are transporters that regulate
the amounts of intermediates from fatty acid oxidation in-
side mitochondria. The mitochondrial matrix bound
Acot2 (1.62 fold, p = 0.05), for example, enhances hepatic
fatty acid oxidation by its transporter activity to prevent
substrate overload [40], which otherwise could impair
β-oxidation [41]. In obese F1 males also Acot4 (1.82
fold, p < 0.02) and Acot3 (6.49 fold, p < 0.08) were up-
regulated, which could indicate high amounts of such
intermediates inside the mitochondrial matrix, leading
to impaired fatty acid oxidation and increased levels
of free fatty acids.
Genes encoding peroxisome proliferator-activated re-
ceptors (Ppara, Pparg, Ppargc1a, Ppargc1b) that promote
β-oxidation and inhibit triglyceride synthesis were not
differentially expressed between F1 males of reciprocal
crosses. In contrast, the opponent sterol regulatory
element–binding factor 1 (Srebf1) which increases fatty
acid and triglyceride synthesis [42] was 1.17 fold higher
expressed (p = 0.03) in the obese F1 males. Many
Srebf1 target genes were increased as well (Ar: 2.38
fold, p = 0.07; Elovl6: 1.32 fold, p = 0.02; Fads1: 1.07
fold, p = 0.02; Fasn: 1.21 fold, p = 0.01; Gpam: 1.13
fold, p = 0.02; Hmgcr: 1.32 fold, p = 0.003; Hsd17b7:
1.14 fold, p = 0.05; Ldlr: 1.10 fold, p = 0.005; Me1:
1.16 fold, p = 0.01; Pgd: 1.15 fold, p = 0.04). Certain
alleles of Srebf1 were found in humans to promote
hepatic fibrogenesis [43], which can develop from
nonalcoholic fatty liver disease. Consistently with
these differences in expression, the hepatic lipase
(Lipc) that degrades triglycerides was by trend down-
regulated in obese F1 males (0.96 fold, p = 0.01).
In a situation, in which fatty acids are preferentially
synthesized and accumulated, while their β-oxidation is
impaired, the cell has to increase energy generation from
alternative fuels. Previous measurements of the respira-
tory quotient of the BFMI inbred mice provided evi-
dence for a higher use of carbohydrates as the main
energy fuel [44]. Succinyl-CoA, for example, is a citrate
cycle intermediate that can be produced from degrad-
ation of certain amino acids but also from the propano-
ate pathway. The moderate up-regulation of Mgll (1.17
fold, p = 0.01), Aldh3a2 (1.11 fold, p = 0.01) and Dak
(1.09 fold, p = 0.02) from the glycerolipid pathway aims
at the conversion of triglycerides to precursor substrates
for subsequent glycolysis. Increased carbohydrate metab-
olism is further supported by up-regulation of the carbo-
hydrate transporters Slc16a7 (1.20 fold, p = 0.0007) and
Slc16a12 (1.13 fold, p = 0.02) in matBFMI (Table 3,
Additional file 3: Table S1).
In humans, Slc16a7 catalyzes the rapid transport of
lactate, pyruvate, branched-chain oxo acids and other
substrates across the plasma membrane of mitochondria
and is regulated by estradiol [45, 46]. This regulation
could contribute to the fact that female F1 offspring of
the BFMI mother are protected against elevated hepatic
triglyceride storage.
Among the highest up-regulated genes in matBFMI
were the cytochrome P450, family 4, subfamily A mem-
bers Cyp4a10 (1.35 fold, p = 0.03) and Cyp4a14 (1.32
fold, p = 0.01), which together with an increase of their
rate limiting regulator Por (1.16 fold, p = 0.06) is an indi-
cator for increased ω-oxidation [47], a prerequisite for
subsequent peroxisomal β-oxidation. These genes were
found to play a part in the development of liver steatosis
[48, 49]. The cytochrome P450 proteins are involved in
the synthesis of cholesterol, steroids, and other lipids.











2 % Dntt (1.24) - 0.04814
Il1r1 (0.74) -
1P-value for differential gene expression between reciprocal F1 groups of males was p < 0.05, minimum fold-change difference >20 %, The innateDB tool was used
for the KEGG pathway analysis. matBFMI – BFMI mother, patBFMI – BFMI father
2Steroid hormone transcription factor binding sites. Esrra/b – estrogen related receptor a/b, ER – estrogen receptor alpha, ERE – estrogen response element,
IR3 - androgen inverted repeats of hexameric half-site separated by 3 bp of spacer
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The proteins encoded by Cyp4a10 and Cyp4a14 hydro-
xylize fatty acids [50, 51]. Recently, fatty acid-hydroxy
fatty acids (FAHFAs) have been discovered as a class of
lipids with anti-diabetic and anti-inflammatory effects
[52]. Higher concentrations of FAHFAs in the obese F1
males due to increased expression of the two Cyp4A
genes would be consistent with similar blood glucose
levels in male F1 offspring of both cross directions
(Table 1).
The hepatic expression of the androgen receptor (Ar)
gene was higher in the obese matBFMI F1 males com-
pared to the lean counterparts (2.38 fold, p = 0.07). The
androgen receptor functions as a steroid-hormone acti-
vated transcription factor [53]. Therefore, Ar could
Table 3 Genes highly differentially expressed between the reciprocal F1 males (p < 0.05, fch > 20 %)
Gene
Symbol1





Slc16a7 10 solute carrier family 16 (monocarboxylic acid transp.), 7 1.91 2.30 1.20 0.0007 Esrrb
Nlrp12 7 NLR family, pyrin domain containing 12 2.66 2.19 0.82 0.0009 ERE
Il1r1 1 interleukin 1 receptor, type I 2.16 1.60 0.74 0.0019 -
St5 7 suppression of tumorigenicity 5 1.97 1.61 0.82 0.0029 -
Hmgcr 13 3-hydroxy-3-methylglutaryl-Coenzyme A reductase 3.01 3.98 1.32 0.0034 -
Scara5 14 scavenger receptor class A, member 5 (putative) 1.23 0.55 0.44 0.0050 -
Gpr110 17 G protein-coupled receptor 110 1.48 0.85 0.57 0.0092 -
Grem2 1 gremlin 2 homolog, cysteine knot superfamily 1.50 1.11 0.74 0.0102 -
Fasn 11 fatty acid synthase 4.47 5.41 1.21 0.0110 ERE
Selenbp2 3 selenium binding protein 2 5.72 4.76 0.83 0.0113 -
Cyp4a14 4 cytochrome P450, family 4, subfam. a, polypept. 14 3.58 4.74 1.32 0.0119 -
Cyp2c38 19 cytochrome P450, family 2, subfamily c, polypet. 38 1.46 2.33 1.60 0.0122 Esrra, Esrrb
Crat 2 carnitine acetyltransferase 1.79 2.27 1.26 0.0128 -
Coq10b 1 coenzyme Q10 homolog B (S. cerevisiae) 1.42 1.98 1.39 0.0138 -
Rai14 15 retinoic acid induced 14 1.98 1.64 0.83 0.0144 -
Mup-ps20 4 major urinary protein, pseudogene 20 1.46 0.51 0.35 0.0145 -
Arntl 7 aryl hydrocarbon receptor nuclear translocator-like 1.90 1.05 0.55 0.0151 -
Acnat2 4 acyl-coenzyme A amino acid N-acyltransferase 2 2.37 3.22 1.36 0.0155 Esrrb, IR3
Abcd2 15 ATP-binding cassette, sub-family D (ALD), 2 1.14 1.72 1.51 0.0157 -
Cyp2c39 19 cytochrome P450, family 2, subfamily c, polypept.39 2.77 3.57 1.29 0.0157 Esrra, Esrrb
Slc45a3 1 solute carrier family 45, member 3 2.15 1.72 0.80 0.0166 -
Sntg2 12 syntrophin, gamma 2 1.75 1.45 0.83 0.0187 -
Per2 1 period circadian clock 2 1.26 1.67 1.32 0.0208 -
Hcn3 3 hyperpolarization-activated, cyclic nucleotide-gated 0.95 1.51 1.60 0.0208 -
Gas6 8 growth arrest specific 6 2.26 2.73 1.21 0.0209 -
Serpina12 12 ser/cys peptidase inhibitor, member 12 2.40 1.94 0.81 0.0211 -
Elovl6 3 ELOVL family member 6, elongation of LCFA 3.20 4.17 1.30 0.0214 -
Acsl3 1 acyl-CoA synthetase long-chain family member 3 2.24 2.71 1.21 0.0215 -
Acot4 12 acyl-CoA thioesterase 4 0.93 1.66 1.79 0.0219 -
Slc20a1 2 solute carrier family 20, member 1 1.54 1.87 1.21 0.0219 -
B3galt1 2 UDP beta 1,3-galactosyltransferase, polypept.1 1.52 1.07 0.70 0.0230 -
Cyp7b1 3 cytochrome P450, family 7, subfamily b, polypept. 1 5.11 4.23 0.83 0.0257 -
Cyp4a10 4 cytochrome P450, family 4, subfamily a, polypept.10 3.78 5.02 1.33 0.0260 ERE, IR3
1Bold gene symbols indicate up regulation in F1 males of a BFMI mother. A list of all differentially expressed genes (p < 0.1) is given in Additional file 1: Table S1.
Chr – chromosome, matBFMI – BFMI mother, patBFMI – BFMI father, Fch – fold-changes
2All values were log-transformed (ln)
3TFBS - Transcription factor binding sites for steroid hormones. Esrrb – estrogen related receptor b, ERE – estrogen response element, IR3 – androgen inverted
repeats of hexameric half-site separated by 3 bp of spacer
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contribute to the sex specific obesity effect. The andro-
gen receptor affects the liver metabolism differently in
males and females [54]. Besides the liver effects, the
androgen receptor protects females against high fat
diet-induced obesity and dyslipidemia [55]. Additional
studies showed that mice lacking the androgen receptor
develop hepatic steatosis and insulin resistance in males
but not females under high fat diet [56].
Among the genes that were highly differentially
expressed between the two groups of F1 males (p < 0.05,
fold-change difference min. 20 %, Table 3), six and two
genes contain binding sites for estrogen (Acnat2,
Cyp2c38, Cyp2c39, Cyp4a10, Fasn, Nlrp12) and andro-
gen (Acnat2, Cyp4a10), respectively. Considering all dif-
ferentially expressed genes under p < 0.05 estrogen (ER),
androgen (AR) or glucocorticoid response (GR) elements
occur in 220 up- (55 ER, 14 AR, 3 GR) and 189 down-
regulated (30 ER, 11 AR, 6 GR) genes in the obese ver-
sus lean F1 males (Additional file 3: Table S1).
We compared the occurrence of these transcription
factor binding sites in genes being differentially
expressed (p < 0.05, >20 % fold-change difference) be-
tween the obese and the non-obese F1 males with ran-
domly selected genes. We found that binding motifs for
estrogen seemed to be under-represented in down-
regulated genes (p = 0.074). However, when relaxing our
restraints and define our down-regulated genes as p < 0.05
and do not filter for only the highest fold-changes (> 20 %),
this under-representation of estrogen binding sites becomes
highly significant (p = 0.004) while androgen binding sites
tended to be over-represented in up-regulated genes
(p = 0.056). Therefore, modifications of these genes as
a result of epigenetic reprogramming during genetic
imprinting or during pregnancy could modify their
expression in response to sex-hormone production
beginning at puberty.
Gene expression of hemizygous genetic elements
Differential gene expression on the X and Y chromo-
some and mitochondria was examined in particular be-
cause these homozygous genomic units can be
polymorphic between the reciprocal crosses. Among
them are the androgen receptor (Ar: 2.38 fold, p = 0.07),
zinc finger protein X-linked (Zfx: 0.84 fold, p = 0.09) and
polyglutamine binding protein 1 (Pqbp1: 1.07 fold, p < 0.1),
which act as transcription factors. Differentially expressed
X chromosomal genes that are involved in the lipid
metabolism are ATP-binding cassette, sub-family D (ALD),
member 1 (Abcd1: 1.22 fold, p = 0.04), HAUS augmin-like
complex, subunit 7 (Haus7: 1.21 fold, p = 0.05), NAD(P)
dependent steroid dehydrogenase-like (Nsdhl: 1.10
fold, p = 0.03), monocarboxylic acid transporter (Slc16a2)
and glycerol kinase (Gyk) (Table 4, Additional file 3: Table
S1). Zfx is well studies in cancer as a proliferation factor;
it is also involved in animal size and fertility and lower
gene expression was found to inhibit cell growth [57, 58].
Dysfunctional Pqbp1 was associated to lipid metabolism
in C. elegans. Repression of this gene led to reduction of
lipid content in mammalian primary white adipocytes and
also triglyceride synthesis from fatty acids was impaired
[59]. Since no differences in expression were found for
genes on the Y-chromosome, we provide further evidence
that the Y chromosome can most likely ruled out as cause
for differences in obesity of males. In the class of
mitochondrial genes we found mitochondrial NADH de-
hydrogenase 1 (mt-Nd1) expressed at a lower level (0.95
fold, p = 0.02) in obese matBFMI F1 males (Table 4).
Quantitative PCR validation
We verified our gene expression fold-change results
from the RNA-seq analyses performing qPCR for Ar,
Peg3 and Srebf1. The qPCR results confirmed the direc-
tion of fold-changes in the obese matBFMI animals for
Fig. 2 Differential gene expression comparing F1 males from reciprocal crosses and parental strains. Heatmap of genes that were differentially expressed
between the reciprocal crosses (p < 0.05) and parental strain gene expression for KEGG pathways of a) biosynthesis of unsaturated fatty acids and b) fatty
acid degradation
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the most genes with Ar being 3.27 fold (p = 0.004) up-
regulated and Peg3 being severely down-regulated
(0.36 fold, p = 0.002; Additional file 2: Table S4).
Srebf1 was found to be 1.66 fold upregulated, al-
though with lower significance (p = 0.065) as com-
pared to the RNA-seq results (p = 0.027). It is
possible that the upregulation of the androgen recep-
tor is a reaction to low androgen levels that are
known to be caused by obesity, though a study in cell
culture found androgens to inhibit Peg3 expression
[60].
Allele specific expression
Since allele-specific expression could result from paren-
tal imprinting, we exploited the sequence information of
expressed genes. After rigorous quality check, we found
Table 4 Differentially expressed genes between patBFMI and matBFMI on X chromosome and mitochondria
Gene
Symbol1







Trmt2b X TRM2 tRNA methyltransferase 2B 2.07 1.83 0.88 0.0008 -
Ssr4 X signal sequence receptor, delta 3.01 2.84 0.94 0.0013 -
Rps4x X ribosomal protein S4, X-linked 4.3 4.17 0.97 0.0026 -
Prdx4 X peroxiredoxin 4 3.63 3.49 0.96 0.0086 -
Shroom2 X shroom family member 2 1.66 1.46 0.88 0.0163 -
Rps24-ps3 X ribosomal protein S24, pseudogene 3 5.17 5.04 0.97 0.0212 -
Gm5763 X predicted pseudogene 5763 0.85 1.52 1.79 0.0255 -
Nsdhl X NAD(P) dependent steroid dehydrogenase-like 3.15 3.47 1.10 0.0331 -
Abcd1 X ATP-binding cassette, sub-family D (ALD), 1 1.37 1.67 1.22 0.0439 -
Mospd2 X motile sperm domain containing 2 1.92 1.88 0.98 0.0456 -
Haus7 X HAUS augmin-like complex, subunit 7 1.85 2.23 1.21 0.0486 Esrrb
Cd99l2 X CD99 antigen-like 2 1.77 1.87 1.06 0.0489 Esrra,Esrrb
Serpina7 X serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase,
antitrypsin), member 7
2.01 2.52 1.25 0.0508 ERE
Pls3 X plastin 3 (T-isoform) 2.84 2.74 0.96 0.0557 -
Tsc22d3 X TSC22 domain family, member 3 3.59 3.20 0.89 0.0667 ADR3
Slc16a2 X solute carrier family 16 (monocarboxylic acid transporters), member 2 2.77 2.62 0.95 0.0668 -
Ar X androgen receptor 0.26 0.62 2.38 0.0678 -
Hsd17b10 X hydroxysteroid (17-beta) dehydrogenase 10 4.21 4.43 1.05 0.0688 -
Tmsb4x X thymosin, beta 4, X chromosome 3.8 3.63 0.96 0.0703 IR3
Gyk X glycerol kinase 2.9 2.97 1.02 0.0790 Esrra,Esrra,
ERE
Gm14760 X predicted gene 14760 3.02 3.18 1.05 0.0803 Esrra,Esrrb
Wdr13 X WD repeat domain 13 1.62 1.7 1.05 0.0831 Esrra, ERE
Gm14373 X predicted gene 14373 2.49 2.41 0.97 0.0858 -
Cldn2 X claudin 2 3.22 3.45 1.07 0.0870 -
Rlim X ring finger protein, LIM domain interacting 2.2 2.12 0.96 0.0910 -
Zfx X zinc finger protein X-linked 1.47 1.23 0.84 0.0915 -
Pqbp1 X polyglutamine binding protein 1 2.53 2.70 1.07 0.0971 -
Lamp2 X lysosomal-associated membrane protein 2 4.14 4.01 0.97 0.0974 Esrra,Esrrb
F8 X coagulation factor VIII 1.99 1.83 0.92 0.0979 -
Gm6472 X predicted pseudogene 6472 4.99 4.90 0.98 0.0997 -
mt-Nd1 MT mitochondrially encoded NADH dehydrogenase 1 6.76 6.42 0.95 0.0165 -
1Bold gene symbols indicate up-regulation in matBFMI. Y chromosomal genes were not differentially expressed. Chr – chromosome, matBFMI – BFMI mother,
patBFMI – BFMI father, Fch – fold-change
2All values were log-transformed (ln)
3TFBS - Transcription factor binding sites for steroid hormones. Esrrb – estrogen related receptor b, ERE – estrogen response element, ADR3 – androgen direct
repeats of the hexameric half-site, IR3 – androgen inverted repeats of hexameric half-site separated by 3 bp of spacer
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47,566 SNPs on autosomes (7,470 not in genes, and
40,096 SNPs in 6,260 genes). After selecting SNPs for
being different between parental strains BFMI and B6N
26,101 SNPs were left (1,846 not in genes, and 24,255
SNPs in 3,961 genes). After selecting for ASE there were
1,362 SNPs left (139 not in genes, and 1,223 SNPs in
415 genes). Filtering those for concordance yielded 1,315
SNPs (137 not in genes, and 1,178 SNPs in 402 genes,
see Additional file 4: Table S2). These SNPs were used
to search for parent-of origin-specific expression in the
liver of 10 week old males. Deviations from balanced
biallelic expression can cause different phenotypes by
causing total gene expression differences but also inde-
pendently since allele functions can be altered due to se-
quence variants, altering the function of gene products.
We found evidence for allelic imbalances for protein
coding genes Abca8b, Commd1, H13, Harbi1, Mcts2,
Peg3, Plg, Prkd3 and Zrsr1 (Table 5).
Paternal allele expression was identified for paternally
expressed 3 (Peg3) and zinc finger (CCCH type), RNA
binding motif and serine/arginine rich 1 (Zrsr1). Mater-
nal allele expression was found for the gene H13. Previ-
ously, all three genes have been described to be
genetically imprinted during gametogenesis and differen-
tially expressed in offspring [61–64]. However, even if
parent-of-origin specific expression is proven, the ex-
pression level of the paternal allele could differ between
offspring due to cis or trans acting regulation that can-
not be derived from RNA-seq data [64]. This was the
case for Peg3 in our study. Interestingly, the obese
matBFMI males showed only 0.31 fold expression of
Peg3 (p = 0.046), which was one of the genes with the
most extreme decrease in expression. Peg3 is a Krüppel
C2H2-type zinc finger protein, which plays a role in the
olfactory system related sexual learning, cell proliferation
and p53-mediated apoptosis [65, 66]. In zebrafish, Peg3
inhibits the Wnt pathway [67]. In our data, lower ex-
pression of Peg3 in in obese males was accompanied by
lower expressions of the Wnt target genes cadherin 1
(Cdh1: 0.75 fold, p = 0.03), epidermal growth factor re-
ceptor (Egfr: 0.85 fold, p = 0.05) and neuropilin 1 (Nrp1:
0.90 fold, p = 0.02). High Peg3 expression was recently
suggested to protect from high-fat diet induced obesity
in F1 offspring of reciprocal crosses between PWK and
B6 [68]. The ‘paternal transmission’ of the Peg3 effect
was deduced from the observation that B6 develop









Gene description patBFMI matBFMI Ratio
diff.
TFBS2
2 91712576 C/T Harbi1 harbinger transposase derived 1 48.1 79.7 31.5 Esrra,
Esrrb
2 152687856 C/T Mcts2 malignant T cell amplified sequence 2 88.9 7.2 81.8 -
2 152704657 A/T H13 histocompatibility 13 18.4 75.9 57.5 -
2 152705549 G/A H13 7.9 100.0 92.1
7 6704437 C/T Peg3 paternally expressed 3 * 93.6 - - -
7 6706584 A/G Peg3 100.0 - -
11 22956525 G/A Commd1 COMM domain containing 1 37.3 57.7 20.3 -
11 22972794 G/T Commd1 98.8 0.0 98.8
11 22974882 G/A Zrsr1 zinc finger (CCCH type), RNA binding motif and serine/arginine rich 1 95.2 4.6 90.7 -
11 109933190 T/C Abca8b ATP-binding cassette, sub-family A (ABC1), member 8b 57.6 30.9 26.7 -
11 109933214 C/T Abca8b 60.8 38.5 22.4
11 109974591 A/C Abca8b 67.7 45.7 22.0
12 104081368 A/G Serpina4-
ps1
serine (or cysteine) peptidase inhibitor, clade A, member 4,
pseudogene 1
24.6 60.9 36.3 -
12 104081522 G/A Serpina4-
ps1
27.2 58.0 30.8
17 12380069 G/T Plg plasminogen 22.6 71.7 49.1 -
17 78969687 T/C Prkd3 protein kinase D3 77.5 57.3 20.2 -
Chr – chromosome, matBFMI – F1 males from BFMI mothers, patBFMI – F1 males from BFMI fathers; * Coverage thresholds for ChiSquare based difference
calculations in Peg3 were not met in all matBFMI samples. However, variant calling annotates all matBFMI samples as reference (B6) at these positions, confirming
the paternal expression. Further ASE gene details are given in Additional file 2: Table S2
1Alternative allele in these cases is the BFMI allele
2TFBS - Steroid hormone transcription factor binding sites. Esrra/b – estrogen related receptor a/b, ERE – estrogen response element
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obesity under high fat diet, whereas PWK mice do not.
Our data suggest that different paternal alleles and ex-
pression levels of Peg3 act differently in heterozygous
BFMI/B6N mice.
Very little is known about the function of the
imprinted gene Zrsr1 although it was associated with
the pluripotency state in induced pluripotent stem cells
[69]. Furthermore, it could be shown that trans-acting
DNA binding proteins, such as methyl-CpG binding do-
main proteins 2 (Mecp2), methyl-CpG binding domain
protein Mbd1 and Mbd3 bind at maternal and paternal
Zrsr1 alleles differently [70]. In our F1 male mice, Zrsr1
was 0.80 fold expressed in the obese F1 males (p = 0.08).
The predominant expression of the maternal H13 allele
was confirmed by our data and the gene was only 0.94
fold expressed (p < 0.05) in the matBFMI males.
Differences in expression of imprinted genes could be
causal for regulation of down-stream genes contributing
to obesity. Recently, paternal intergenerational metabolic
reprogramming was found in drosophila, where paternal
fat-diet led to changes in the germ cell chromatin state,
transcription patterns and modified offspring metabol-
ism. The genetic factors identified in drosophila have
been verified in mouse and human studies [71].
We also found a lower proportion of the BFMI Abca8b
allele expressed by the obese matBFMI males. While the
patBFMI expressed between 58–68 %, the matBFMI
expressed only 31–46 % of the BFMI allele. This corre-
sponds to a mean difference for the alternative allele pro-
portion of 24 % under a fold-change of 0.87 (p = 0.06) in
total gene expression. ATP-binding cassette (ABC) trans-
porter genes represent the largest family of transmem-
brane proteins, which arrange the transport of various
molecules across all cell membranes utilizing energy from
bound ATP. Most ABC genes move compounds from the
cytoplasm to the outside of the cell or into an extracellular
compartment (endoplasmic reticulum, mitochondria, per-
oxisome). ABC transporters shuttle hydrophobic com-
pounds within the cell as part of a metabolic process or
outside the cell for transport to other organs or secretion
from the body. The Abca subfamily includes the largest
Abc genes (several >2000 amino acids) and its members
are involved in transport of vitamin A (retinol, etc.) deriv-
atives as well as in disorders of cholesterol transport and
high-density lipoproteins (HDL) biosynthesis [72]. Our
data from pathway analyzes and ASE indicate that altered
functions of ABC transporters (mainly subfamily Abca
and Abcd) contribute to the accumulation of body fat in
the obese matBFMI males.
Conclusions
In reciprocal crosses between the obese line BFMI
and the lean line B6N, we observed high fat depos-
ition with and without cross-fostering beginning at
puberty only in male F1 offspring of obese BFMI
mothers, but not in females of the same cross and
males and females of the reciprocal cross. Gene ex-
pression analysis of liver RNA provided evidence for
higher expression of genes controlling fat deposition
and impaired β-oxidation of lipids as well as effects
on the circadian rhythm in the obese F1 males. The
obese F1 males likely use more carbohydrates and
amino acids for energy production than lean males.
Among the extremely up-regulated genes were Cyto-
chrome A4 genes leading to hydroxylation of fatty
acids. Furthermore, typical imprinted genes were dif-
ferentially expressed between the two groups of males
in reciprocal crosses.
The observations led us to the conclusion that
parent-of-origin effects during gametogenesis and
pregnancy play a significant role for the development
of obesity in later life. Postnatal maternal effects sig-
nificantly influence fat deposition, but could not en-
tirely overwrite perinatal parent-of-origin-effects.
Reprogramming of gametes and metabolic imprints
during pregnancy set epigenetic marks that lead to
differential expression of genes in response to sex-
hormone activation beginning at puberty. We suggest
that the obese F1 males store more fat due to im-
paired β-oxidation and cellular compound transport.
They compensate the lower energy production from
fatty acids by an increased use of alternative fuels for
the mitochondrial and non-mitochondrial energy pro-
duction. The hydroxylases Cyt4a10 and Cyp4a14 are
suggested to contribute to increased fatty liver, but
the hydroxylated fatty acids are likely nonhazardous.
The imprinted genes Peg3, Zrsr1, und H13 and the
androgen receptor might play important sex-specific
roles for affected down-stream signaling and meta-
bolic pathways. We further suggest that the Y and X
chromosomes as well as mitochondria play a minor
role in the identified phenotypic differences.
Since the higher adipose tissue mass in F1 males of the
BFMI mother was maintained during cross-fostering,
parent-of-origin effects of genomic reprogramming during
gametogenesis and maternal effects during pregnancy
could be causal for the elevated fat accumulation.
Although, we found indicators for substrate inhibition
circuits in mitochondria, the hypothesis of impaired sub-
strate selection or mitochondrial substrate overload by
fatty acids in BFMI mitochondria needs further research.
Furthermore, we like to point out that allele-specific-
expression analysis with RNA-seq data requires high
control standards. Allele-specific expression could only
be tested, if sequence variation was identified between
the examined mouse strains. Since the analysis per-
formed in this study was very conservative, the data we
present here are highly reliable. Nonetheless, we miss
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information on genes without variation in the coding se-
quence and genes with very low transcript levels in liver.
Moreover, the molecular mechanisms necessary for allele
specific expression in adult tissues need further evalu-
ation. A controlling function of sex hormones in metab-
olism was shown before and is supported by reduced
counts of binding sites for estrogens in down-regulated
genes in our data.
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